249 related articles for article (PubMed ID: 19554778)
1. [Bringing the antiviral therapy home for chronic hepatitis B patients: host immunity influences the efficacy and disease prognosis].
Wang FS; Zhang JY
Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):164-6. PubMed ID: 19554778
[No Abstract] [Full Text] [Related]
2. [Management of HBeAg negative chronic hepatitis B].
Jia JD
Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):539. PubMed ID: 16042896
[No Abstract] [Full Text] [Related]
3. [Lamivudine treatment consensus from relative experts in 2003].
Lamivudine Clinical Practice Group
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):497-9. PubMed ID: 12939188
[No Abstract] [Full Text] [Related]
4. [Antiviral effects of entecavir in patients with hepatitis B virus-related cirrhosis].
Xu Y; Wang JB; Xu J; Jiao J; Zhang YG; Ji SW; Zhao P; Guo HH; Li Y; Zhou CY
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):109-12. PubMed ID: 20196949
[TBL] [Abstract][Full Text] [Related]
5. Antiviral therapy for chronic hepatitis B.
Jafri SM; Lok AS
Clin Liver Dis; 2010 Aug; 14(3):425-38. PubMed ID: 20638023
[TBL] [Abstract][Full Text] [Related]
6. [Effect of interferon neutralization antibody in the treatment of chronic hepatitis B with interferon].
CHEN XR; WANG HL; XUAN MX; MAO XG; SUN JG; WAN BM
Zhonghua Gan Zang Bing Za Zhi; 2009 May; 17(5):385-6. PubMed ID: 19497208
[No Abstract] [Full Text] [Related]
7. [Interferon therapy for chronic hepatitis B].
Kakumu S
Nihon Rinsho; 2004 Aug; 62 Suppl 8():315-20. PubMed ID: 15453337
[No Abstract] [Full Text] [Related]
8. Hepatitis B virus infection--natural history and clinical consequences.
Ganem D; Prince AM
N Engl J Med; 2004 Mar; 350(11):1118-29. PubMed ID: 15014185
[No Abstract] [Full Text] [Related]
9. Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy.
Liaw YF
Antivir Ther; 2006; 11(6):669-79. PubMed ID: 17310811
[TBL] [Abstract][Full Text] [Related]
10. [Effects of lamivudine and interferon-alpha combination therapy on chronic hepatitis B].
Tang Y; Chen G; Zheng R
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):89. PubMed ID: 11983118
[No Abstract] [Full Text] [Related]
11. [Are phyllanthus species effective in hepatitis B?].
Rakowitz B
Dtsch Med Wochenschr; 2011 Jul; 136(28-29):1460. PubMed ID: 21732258
[No Abstract] [Full Text] [Related]
12. [A reduction study of seroconversion of HBsAg in chronic hepatitis B patients with HBeAg positive by combination treatment with interferon and lamivudine].
Yu SL; Qin LY; Wang C; Yu LJ; Guo CY; Wang YZ
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):472-3. PubMed ID: 19567034
[No Abstract] [Full Text] [Related]
13. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B.
Su TH; Hsu CS; Chen CL; Liu CH; Huang YW; Tseng TC; Liu CJ; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2010; 15(8):1133-9. PubMed ID: 21149920
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus serology to predict antiviral response in chronic hepatitis B.
Kim BK; Han KH; Ahn SH
Digestion; 2011; 84 Suppl 1():29-34. PubMed ID: 22156483
[TBL] [Abstract][Full Text] [Related]
15. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
16. [Association between IgG antibody against the C-terminal region of the preS1 protein of hepatitis B virus and the early response to interferon therapy in chronic hepatitis B].
Xia GM; Zhang ZH; Wei SF; Gao YF; Zhang TT; Zhang L; Li X
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):1-4. PubMed ID: 20128959
[TBL] [Abstract][Full Text] [Related]
17. Chronic HBV without e antigen: using HBV DNA to guide management.
Tran T; Martin P
Am J Gastroenterol; 2003 Oct; 98(10):2115-7. PubMed ID: 14572554
[No Abstract] [Full Text] [Related]
18. Response predictors and results of a long-term treatment with lamivudine in patients with chronic hepatitis B.
Mihm U; Sarrazin C; Herrmann E; Teuber G; von Wagner M; Kronenberger B; Zeuzem S
Z Gastroenterol; 2003 Mar; 41(3):249-54. PubMed ID: 12664345
[TBL] [Abstract][Full Text] [Related]
19. [Corticosteroid withdrawal therapy in patients with chronic hepatitis B virus infection].
Akuta N; Kumada H
Nihon Rinsho; 2004 Aug; 62 Suppl 8():345-8. PubMed ID: 15453343
[No Abstract] [Full Text] [Related]
20. [Early prediction of lamivudine response in e antigen-negative chronic hepatitis B patients].
Li JG; Li JX; Liu MX; Qin HQ; Chai YY; Wang XY; Li SF; Tian SW; Zhao LF; Niu Q; Zhang JQ
Zhonghua Gan Zang Bing Za Zhi; 2009 Oct; 17(10):745-9. PubMed ID: 19874689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
